Advertisement
Advertisement
U.S. Markets open in 5 hrs 44 mins
Advertisement
Advertisement
Advertisement
Advertisement

Seelos Therapeutics, Inc. (SEEL)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
0.8600-0.0199 (-2.26%)
At close: 04:00PM EST
0.8222 -0.04 (-4.40%)
After hours: 07:55PM EST
Advertisement
Full screen
Loading interactive chart...
  • PR Newswire

    Seelos Therapeutics Doses First Patients in an Ethnobridging Study with SLS-002 (Intranasal Racemic Ketamine)

    Seelos Therapeutics, Inc. (Nasdaq: SEEL), a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system disorders and rare diseases, today announced that it has dosed the first patients in an ethnobridging study in healthy adult Japanese and non-Asian subjects to compare the safety and pharmacokinetic profiles of SLS-002 (intranasal racemic ketamine). Seelos consulted and received endorsement from the Pharmaceuticals and Medical Devices Agency (PMD

  • PR Newswire

    Seelos Therapeutics to Participate in the 12th Annual LifeSci Partners Corporate Access Event

    Seelos Therapeutics, Inc. (Nasdaq: SEEL), a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system disorders and rare diseases, today announced that it will participate in the 12th Annual LifeSci Partners Corporate Access Event, to be held in San Francisco, California on January 9-11th, 2023.

  • Benzinga

    Parkinson's Study Using CRISPR Technology Shows Promise, Seelos Therapeutics Says

    Seelos Therapeutics Inc (NASDAQ: SEEL) announced in vivo data demonstrating that a single dose of SLS-004 downregulated the production of alpha-synuclein (α-synuclein). This reduction of α-synuclein by SLS-004 in an established α-synuclein overexpressing animal model of Parkinson's disease (PD) resulted in a substantial increase and recovery of degeneration in tyrosine hydroxylase positive (TH+) dopaminergic neurons. TH+ dopaminergic neurons in the midbrain region, called substantia nigra pars c

Advertisement
Advertisement